ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2026
Effect of taxane
Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivesBreast cancer-related lymphedema (BCRL) is a common complication of breast cancer treatment. Previous studies have suggested an association between BCRL and adjuvant chemotherapy; however, whether taxane-based regimens independently influence the risk of BCRL remains controversial due to potential confounding factors. Propensity score matching (PSM) can effectively reduce confounding bias. This study aims to investigate the association between taxane-based adjuvant chemotherapy and BCRL using PSM.
methodsThis retrospective study was conducted using data from the electronic medical record system of Xiangya Third Hospital, Central South University. BCRL was diagnosed based on objective measurements of limb circumference. Taxane-based adjuvant chemotherapy was defined as chemotherapy regimens including docetaxel, paclitaxel, or albumin-bound paclitaxel. PSM was applied to control for potential confounders, followed by Logistic regression analysis in the matched cohort to evaluate the association between taxane-based chemotherapy and BCRL.
resultsA total of 1 494 patients were included in this study. Before PSM, taxane-based adjuvant chemotherapy was not significantly associated with BCRL (
conclusionsTaxane-based adjuvant chemotherapy is not an independent risk factor for BCRL, regardless of adjustment for known confounding factors. Further multicenter, prospective studies are warranted to further validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.